Medical Biomimetics Market held over USD 27.4 billion in 2020 and is to grow with a CAGR of 5.4% from 2020-2030. Biomimetics is an interdisciplinary field of chemistry, engineering and biology principles. The concepts are applicable to the synthesis of materials, devices, or synthetic structures consisting of functions or operations mimicking biological processes; Biomaterials are known as synthetic or natural materials which display interaction with any part of a biological system. Biomimetic designs are used in tissue engineering, drug delivery and regenerative medicine. More precisely, medical biomimetics is a innovative type of technology that uses nature or significantly mimics it in a bid to better human lives. Some examples of medical biomimetics include the skin structure of sharks.
Market Dynamics and Factors:
The growing geriatric population and subsequent growth in demand for prothesis and implants are one of the key factors expected to drive the medical biomimetics global market. The high rate of organ insufficiency within geriatrics will stimulate the increased use in organ regeneration of biomimetic technology. Over the next couple of years, significant advances over tissue engineering are expected to lead to a successful change in the field of organ transplantation and the application of biomimetic technologies for organ regeneration. Cardiology, dentistry, ophthalmology and orthopedics compose the medical areas using biomimetics. Growing tissue engineering market will further foster the medical biomimetics industry growth.
Market Segmentation:
Based on the product, the medical biomimetics market industry is bifurcated into cardiovascular, Dental, Ophthalmology and orthopedic. Cardiovascular has been further divided into Prostheses, Exoskeleton. On the basis of application, the medical biomimetics market trends vary into plastic surgery, wound healing, tissue engineering, drug delivery, others. Geographical breakdown and analysis of each of the aforementioned segments includes regions comprising North America, Europe, Asia-Pacific, and ROW.
Geographic Analysis:
In the coming years the demand for medical biomimetics market is expected to grow rapidly. The medical biomimetics market is expected to increase on account of growing count of geriatric population, increase in organ failure rates, rising use of bio-mimetic engineering technologies for organ regeneration, increased applications in tissue engineering, increase in R&D activities and developments in nanotechnology. Moreover, public private partnerships will drive the market for medical biomimetics by increasing the application of medical biomimetics in the field of healthcare, in noninvasive techniques including CT scans, electronic equipment (ECG) and ultrasound.
Competitive Scenario:
Global medical biomimetics market, is highly competitive, consists of a few major players. Few companies are also adopting novel launch and development strategies to reap benefits in the emerging market. Key companies are also expanding their manufacturing facilities to cater to growing demand for this drug globally. Key players enhancing the global Medical Biomimetics market size include Forschungszentrum Jülich GmbH, Avinent Implant System, Abbott, BioMimetic Laboratories, Inc., Hstar Technologies Corporation, BioHorizons,Veryan Medical and SynTouch LLC.
Medical Biomimetics Market Report Scope
Report Attribute | Details |
Analysis Period | 2020–2030 |
Base Year | 2021 |
Forecast Period | 2022–2030 |
Market Size Estimation | Billion (USD) |
Growth Rate (CAGR%) | 5.4 % |
| By Product [Cardiovascular, Orthopedic (Prostheses, Exoskeleton), Ophthalmology, Dental], By Application (Plastic Surgery, Wound Healing, Tissue Engineering, Drug Delivery) |
Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
Key Companies Profiled | Forschungszentrum Jülich GmbH, Avinent Implant System, Abbott, BioMimetic Laboratories, Inc., Hstar Technologies Corporation, BioHorizons,Veryan Medical and SynTouch LLC. |